- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 670.71M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 675.15M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 634.71M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $1.16M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $39.27M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $37.84M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $194.25M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $35.74M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $19.57M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $59.64M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $587.55M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $241.56M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $23.67M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.57B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.59B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.07B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.04B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $193.85M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $231.56M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $805.48M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $969M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $957.64M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $629.34M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.38B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.56B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.05 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $15.75M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $12M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$19.03M |
| Net Income | Q1 2026 · Mar 31, 2025 | $28.87M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $223.11M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $47.41M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $253.26M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $68.68M |